DESyne BDS Plus system with site-specific antithrombotic therapeutic (TRx) significantly reduced the risk of TLF versus conventional drug-eluting stent through 12-months
News | Cardiovascular Clinical Studies
Elixir Medical’s Late-Breaking 12-Month Data Demonstrate Significant Improvement in Safety and Effectiveness of World’s First Site-Specific Antithrombotic Therapeutic Compared to DES

June 3, 2024 — Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease ...

Home June 03, 2024
Home
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
News
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation

June 3, 2024 — HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve ...

Home June 03, 2024
Home
Acquisition creates greater opportunity to transform the treatment landscape for cardiovascular disease
News | Cardiovascular Business
Johnson and Johnson Completes Acquisition of Shockwave Medical

May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...

Home May 31, 2024
Home
Conference focuses on rapidly expanding field of sports cardiology and increasing demand for CV care teams who care for athletes
News | Cardiovascular Education
American College of Cardiology Announces Care of the Athletic Heart

May 31, 2024 — In the United States there are over 8 million active athletes. Given the rapid expansion of sports ...

Home May 31, 2024
Home
Cardiologists performed the fewest biopsies after dual negative HeartCare results compared to single or dual positive results
News | Cardiovascular Clinical Studies
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

May 31, 2024 — CareDx, a leading precision medicine company focused on the discovery, development, and commercialization ...

Home May 31, 2024
Home
This collaboration integrates HBox.ai's virtual care model with InfoBionic.AI's advanced cardiac telemetry, offering AI-driven tools for virtual consults, remote monitoring, and diagnostic care
News | Artificial Intelligence
InfoBionic.Ai and HBox.ai Ink Partnership to Offer the First AI-Driven "Cardiology Clinic of the Future"

May 31, 2024 — InfoBionic.ai and HBox.ai announced a groundbreaking partnership that brings together the leading AI ...

Home May 31, 2024
Home
Elixir Medical recently announced that the PINNACLE I study, evaluating the safety and performance of its LithiX Hertz Contact Intravascular Lithotripsy System (IVL) met its primary safety and effectiveness endpoint of clinical success. Shown here: Elixir Medical CEO Motasim Sirhan.
News | EuroPCR
Elixir Medical PINNACLE I Study of LithiX IVL System Meets Primary Endpoints of Clinical Success

May 30, 2024 — Elixir Medical, a developer of technologies to treat cardiovascular and peripheral disease, announced ...

Home May 30, 2024
Home
Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heart rhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
News | EP Lab
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
This AI-powered device enables even non-expert ultrasound users
News | Cardiovascular Ultrasound
AI-Powered Ultrasound Device Enhances Cardiac Monitoring for Chemotherapy Patients

May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...

Home May 30, 2024
Home
New data presented at LINC 2024 support use of thin-strut cobalt chromium stent in calcified iliac lesions
News | Stents Bioresorbable
One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System

May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...

Home May 30, 2024
Home
Data was presented today byAstraZeneca, at the European Atherosclerosis Society (EAS) Congress in France,on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL-C reduction on top of statin in Phase I trial.
News | Cardiovascular Clinical Studies
Oral PCSK9 Inhibitor Demonstrated Significant LDL-C Reduction on Top of Statin in Phase I Trial Presented at EAS Congress

May 29, 2024 — Data was presented by AstraZeneca on AZD0780, an oral PCSK9 inhibitor which demonstrated significant LDL ...

Home May 29, 2024
Home
ROC curves of classification of healthy control (HC) and CHDs.
News | Transesophageal Echo (TEE)
An Auxiliary CHD Diagnostic System Based on Multi-view and Multi-modal Transthoracic Echocardiograms

May 29, 2024 — Congenital heart disease (CHD) is one of the most common congenital anomalies worldwide, which brings a ...

Home May 29, 2024
Home
Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with heart failure, according to research presented at Heart Failure 2024
News | Heart Failure
Heart Failure Patients Who Do Yoga Have Stronger Hearts and Can be More Active

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
The American Heart Association has issued a statement warning that false information about COVID vaccination and heart defects attributed to the Association may be spreading.
News | AHA
American Heart Association Warns of Misinformation Connecting COVID Vaccination to Heart Defects

May 24, 2024 — The American Heart Association has issued a statement warning that false information about COVID ...

Home May 24, 2024
Home
Analysis adds to the body of evidence differentiating INPEFA as a dual oral inhibitor of SGLT2 and SGLT1
News | Pharmaceuticals
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That Inpefa (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now